Cargando…

Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy

PURPOSE: To evaluate the efficacy and safety of oral mineralocorticoid-receptor antagonist (MRa) therapy in three clinical presentations of nonresolving central serous chorioretinopathy (CSCR) with chronic epitheliopathy. METHODS: Retrospective case series of consecutive patients with nonresolving C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daruich, Alejandra, Matet, Alexandre, Dirani, Ali, Gallice, Mathilde, Nicholson, Luke, Sivaprasad, Sobha, Behar-Cohen, Francine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Association for Research in Vision and Ophthalmology 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782825/ https://www.ncbi.nlm.nih.gov/pubmed/26966638 http://dx.doi.org/10.1167/tvst.5.2.2

Ejemplares similares

Proteome and Metabolome of Subretinal Fluid in Central Serous Chorioretinopathy and Rhegmatogenous Retinal Detachment: A Pilot Case Study
por: Kowalczuk, Laura, et al.
Publicado: (2018)

ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration
por: Daruich, Alejandra, et al.
Publicado: (2017)

SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A Randomized Controlled Crossover Study
por: Bousquet, Elodie, et al.
Publicado: (2015)

Levels of the oxidative stress biomarker malondialdehyde in tears of patients with central serous chorioretinopathy relate to disease activity
por: Daruich, Alejandra, et al.
Publicado: (2020)

Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy
por: Chin, Eric K, et al.
Publicado: (2015)

Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy
por: Abd Elhamid, Ahmed Hosni
Publicado: (2015)

High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy
por: Bousquet, Elodie, et al.
Publicado: (2023)

Lipocalin 2 as a potential systemic biomarker for central serous chorioretinopathy
por: Matet, A., et al.
Publicado: (2020)

Predictive factors of selective mineralocorticoid receptor antagonist treatment in chronic central serous chorioretinopathy
por: Gergely, Róbert, et al.
Publicado: (2020)

Mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy: systematic review and meta-analyses
por: Felipe, Camila Q., et al.
Publicado: (2022)

Mineralocorticoid Receptor Antagonist Treatment for Steroid-Induced Central Serous Chorioretinopathy Patients with Continuous Systemic Steroid Treatment
por: Kim, Jin Young, et al.
Publicado: (2018)

Multimodal Imaging in the Management of Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy
por: Hagag, Ahmed M., et al.
Publicado: (2020)

Management of central serous chorioretinopathy: Expert panel discussion
por: Chhablani, Jay, et al.
Publicado: (2018)

EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE
por: Kowalczuk, Laura, et al.
Publicado: (2017)

Changes in choroidal blood flow velocity in patients diagnosed with central serous chorioretinopathy during follow-up for pachychoroid pigment epitheliopathy
por: Saito, Wataru, et al.
Publicado: (2020)

Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathy
por: Hanumunthadu, Daren, et al.
Publicado: (2019)

OCT Angiography Fractal Analysis of Choroidal Neovessels Secondary to Central Serous Chorioretinopathy, in a Caucasian Cohort
por: Serra, Rita, et al.
Publicado: (2022)

Nonresolving inflammation redux
por: Nathan, Carl
Publicado: (2022)

Ocular steroidome in human eyes and in eyes with complex central serous chorioretinopathy (CSCR)
por: Zola, Marta, et al.
Publicado: (2023)

Real-world practice patterns of eplerenone use for central serous chorioretinopathy
por: Venkatesh, Ramesh, et al.
Publicado: (2023)

Acute Central Serous Chorioretinopathy Subtypes as Assessed by Multimodal Imaging
por: Arrigo, Alessandro, et al.
Publicado: (2021)

Mid-Phase Hyperfluorescent Plaques Seen on Indocyanine Green Angiography in Patients with Central Serous Chorioretinopathy
por: Bousquet, Elodie, et al.
Publicado: (2021)

Clinical Characteristics and Multimodal Imaging Findings of Central Serous Chorioretinopathy in Women versus Men
por: Bousquet, Elodie, et al.
Publicado: (2022)

Resolution of foveal detachment in dome-shaped macula after treatment by spironolactone: report of two cases and mini-review of the literature
por: Dirani, Ali, et al.
Publicado: (2014)

An elderly male with nonresolving consolidation
por: Iyer, Hariharan, et al.
Publicado: (2021)

CENTRAL SEROUS CHORIORETINOPATHY: High-Resolution Imaging of Asymptomatic Fellow Eyes Using Adaptive Optics Scanning Laser Ophthalmoscopy
por: Gerardy, Melvin, et al.
Publicado: (2022)

The Genetic Background of Central Serous Chorioretinopathy: A Review on Central Serous Chorioretinopathy Genes
por: Giannopoulos, Konstantinos, et al.
Publicado: (2021)

Association of Central Serous Chorioretinopathy with Psychosocial Factors is Dependent on Its Phase and Subtype
por: Kim, Yong-Kyu, et al.
Publicado: (2018)

Traumatic central serous chorioretinopathy
por: Ramchandani, Suresh, et al.
Publicado: (2015)

Traumatic central serous chorioretinopathy
por: Steeples, Laura, et al.
Publicado: (2015)

Atypical Central Serous Chorioretinopathy
por: Cebeci, Zafer, et al.
Publicado: (2017)

Biomarkers for central serous chorioretinopathy
por: Nkrumah, Gideon, et al.
Publicado: (2020)

Central Serous Chorioretinopathy Classification
por: Vilela, Manuel, et al.
Publicado: (2020)

Brachytherapy for Central Serous Chorioretinopathy
por: Arora, Supriya, et al.
Publicado: (2022)

Central serous chorioretinopathy in pregnancy
por: Ochinciuc, Radu, et al.
Publicado: (2022)

Central serous chorioretinopathy: Treatment
por: Park, Jong Beom, et al.
Publicado: (2022)

Surgical Management of an Infant with Nonresolving Pneumonia
por: Prabhudesai, Sumant, et al.
Publicado: (2022)

Epithéliopathie rétinienne diffuse
por: Abaloun, Yassine, et al.
Publicado: (2017)

Macular dystrophy associated with the mitochondrial DNA A3243G mutation: pericentral pigment deposits or atrophy? Report of two cases and review of the literature
por: Daruich, Alejandra, et al.
Publicado: (2014)

Central serous chorioretinopathy secondary to trauma
por: Jackson, Thomas E., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v0cpgqs448pgt2tq8poi49l6rp